Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 6/2010

Open Access 01-12-2010 | Brief Report

Biomarker Testing to Estimate Under-Reported Heavy Alcohol Consumption by Persons with HIV Initiating ART in Uganda

Authors: Judith A. Hahn, Mwebesa B. Bwana, Martin A. Javors, Jeffrey N. Martin, Nneka I. Emenyonu, David R. Bangsberg

Published in: AIDS and Behavior | Issue 6/2010

Login to get access

Abstract

Alcohol affects the transmission and treatment of HIV, yet may be under-reported in resource-limited settings. We compared self-reported alcohol consumption with levels of plasma carbohydrate-deficient transferrin (%CDT), a biomarker of heavy alcohol consumption, in persons initiating antiretroviral therapy in Uganda. Almost seven percent (6.7%) of persons reporting abstaining and 10% reporting consuming 1–40 drinks in the prior month tested positive for %CDT, and actual under-report may be higher due to low sensitivity of %CDT. These results suggest likely under-report in those reporting abstaining and current drinking. Improved identification of heavy alcohol consumption is needed for research and clinical purposes.
Literature
1.
Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis. 2007;34(11):856–63.CrossRefPubMed
2.
Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180–202.CrossRefPubMed
3.
Hahn JA, Samet JH. Alcohol and HIV disease progression: weighing the evidence. Curr HIV AIDS Rep. 2010 (in press).
4.
5.
Hahn JA, Maier M, Byakika-Tusiime J, Oyugi JH, Bangsberg DR. Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in kampala, Uganda. J Int Assoc Physicians AIDS Care (Chic Ill). 2007;6(2):83–6.CrossRef
6.
Bergstrom JP, Helander A. Clinical characteristics of carbohydrate-deficient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers. Alcohol Alcohol. 2008;43(4):436–41.PubMed
7.
Golka K, Wiese A. Carbohydrate-deficient transferrin (CDT)–a biomarker for long-term alcohol consumption. J Toxicol Environ Health. 2004;7(4):319–37.CrossRef
8.
Helander A, Carlsson S. Carbohydrate-deficient transferrin and gamma-glutamyl transferase levels during disulfiram therapy. Alcohol Clin Exp Res. 1996;20(7):1202–5.CrossRefPubMed
9.
Helander A, Husa A, Jeppsson JO. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem. 2003;49(11):1881–90.CrossRefPubMed
10.
Bianchi V, Ivaldi A, Raspagni A, Arfini C, Vidali M. Use of carbohydrate-deficient transferrin (CDT) and a combination of GGT and CDT (GGT-CDT) to assess heavy alcohol consumption in traffic medicine. Alcohol Alcohol. 2010;45:247–51.PubMed
11.
Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ. Biochemical markers of alcoholism. Clin Chem Lab Med. 2007;45(8):953–61.CrossRefPubMed
12.
Papas RK, Sidle JE, Wamalwa ES, et al. Estimating alcohol content of traditional brew in western Kenya using culturally relevant methods: the case for cost over volume. AIDS Behav. 2010;14(4):836–44.CrossRefPubMed
Metadata
Title
Biomarker Testing to Estimate Under-Reported Heavy Alcohol Consumption by Persons with HIV Initiating ART in Uganda
Authors
Judith A. Hahn
Mwebesa B. Bwana
Martin A. Javors
Jeffrey N. Martin
Nneka I. Emenyonu
David R. Bangsberg
Publication date
01-12-2010
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9768-y

Other articles of this Issue 6/2010

AIDS and Behavior 6/2010 Go to the issue

Original Paper

HIV Symptoms and Health-Related Quality of Life Prior to Initiation of HAART in a Sample of HIV-Positive South Africans

Original Paper

Biological Validation of Self-Reported Condom Use Among Sex Workers in Guinea

OriginalPaper

Substance Use in HIV-Infected Women During Pregnancy: Self-Report Versus Meconium Analysis

Original Paper

Physiological and Psychosocial Factors that Predict HIV-Related Fatigue

Brief Report

How Researchers Define Vulnerable Populations in HIV/AIDS Clinical Trials

Original Paper

Social Grants, Welfare, and the Incentive to Trade-Off Health for Income among Individuals on HAART in South Africa

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits